Halofuginone suppresses growth of human uterine leiomyoma cells in a mouse xenograft model

Halofuginone inhibits colorectal cancer growth through suppression of Akt/mTORC1 signaling and glucose metabolism

(2015) Guo-Qing Chen et al.   Oncotarget

Anticancer activity of halofuginone in a preclinical model of osteosarcoma: inhibition of tumor growth and lung metastases

(2015) Audrey Lamora et al.   Oncotarget

Myofibroblasts in Pulmonary and Brain Metastases of Alveolar Soft-Part Sarcoma: A Novel Target for Treatment?

(2015) Olga Genin et al.   NEOPLASIA

The chemistry and biology of febrifugine and halofuginone

(2014) Noel P. McLaughlin et al.   BIOORGANIC & MEDICINAL CHEMISTRY

Down-Regulation of miR-29b Is Essential for Pathogenesis of Uterine Leiomyoma

(2014) Wenan Qiang et al.   ENDOCRINOLOGY

Halofuginone-Induced Amino Acid Starvation Regulates Stat3-Dependent Th17 Effector Function and Reduces Established Autoimmune Inflammation

(2014) T. J. Carlson et al.   JOURNAL OF IMMUNOLOGY

Extracellular Matrix Collagen Alters Cell Proliferation and Cell Cycle Progression of Human Uterine Leiomyoma Smooth Muscle Cells

(2013) Faezeh Koohestani et al.   PLoS One

Halofuginone inhibits multiple myeloma growth in vitro and in vivo and enhances cytotoxicity of conventional and novel agents

(2012) Merav Leiba et al.   BRITISH JOURNAL OF HAEMATOLOGY

Characterization of Plasmodium Liver Stage Inhibition by Halofuginone

(2012) Emily R. Derbyshire et al.   ChemMedChem

A portrait of Transforming Growth Factor β superfamily signalling: Background matters

(2012) Daniel Horbelt et al.   INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY

Leiomyoma: genetics, assisted reproduction, pregnancy and therapeutic advances

(2012) Gary Levy et al.   JOURNAL OF ASSISTED REPRODUCTION AND GENETICS

Local inhibition of angiogenesis by halofuginone coated silicone materials

(2012) Martin C. Jordan et al.   JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE

Estimation of Estradiol in Mouse Serum Samples: Evaluation of Commercial Estradiol Immunoassays

(2011) Daniel J. Haisenleder et al.   ENDOCRINOLOGY

Alternatives to hysterectomy

(2011) Dale W. Stovall   MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY

Pharmacological therapy for abnormal uterine bleeding

(2011) JoAnn V. Pinkerton   MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY

Halofuginone Has Anti-Proliferative Effects in Acute Promyelocytic Leukemia by Modulating the Transforming Growth Factor Beta Signaling Pathway

(2011) Lorena L. de Figueiredo-Pontes et al.   PLoS One

Risk assessment of coccidostatics during feed cross-contamination: Animal and human health aspects

(2011) J.L.C.M. Dorne et al.   TOXICOLOGY AND APPLIED PHARMACOLOGY

Efficacy of halofuginone lactate in the prevention of cryptosporidiosis in dairy calves

(2011) L. A. Trotz-Williams et al.   VETERINARY RECORD

Progesterone Is Essential for Maintenance and Growth of Uterine Leiomyoma

(2010) Hiroshi Ishikawa et al.   ENDOCRINOLOGY

Proceedings from the National Institute of Child Health and Human Development Conference on the Uterine Fibroid Research Update Workshop

(2010) William H. Catherino et al.   FERTILITY AND STERILITY

Phase II AIDS Malignancy Consortium Trial of Topical Halofuginone in AIDS-Related Kaposi Sarcoma

(2010) Henry B Koon et al.   JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES

Inhibition of Pancreatic Stellate Cell Activation by Halofuginone Prevents Pancreatic Xenograft Tumor Development

(2010) Itai Spector et al.   PANCREAS

An endocrine-disrupting chemical, fenvalerate, induces cell cycle progression and collagen type I expression in human uterine leiomyoma and myometrial cells

(2010) Xiaohua Gao et al.   TOXICOLOGY LETTERS

Halofuginone enhances the radiation sensitivity of human tumor cell lines

(2009) John A. Cook et al.   CANCER LETTERS

The antifibrotic drug halofuginone inhibits proliferation and collagen production by human leiomyoma and myometrial smooth muscle cells

(2009) Meagan M. Grudzien et al.   FERTILITY AND STERILITY

Inhibition of Transforming Growth Factor β Signaling by Halofuginone as a Modality for Pancreas Fibrosis Prevention

(2009) Orit Zion et al.   PANCREAS

Functional resolution of fibrosis in mdx mouse dystrophic heart and skeletal muscle by halofuginone

(2008) Kyla D. Huebner et al.   AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY

Halofuginone prevents extracellular matrix deposition in diabetic nephropathy

(2008) Seiya Sato et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Prevention of muscle fibrosis and improvement in muscle performance in the mdx mouse by halofuginone

(2008) Tidhar Turgeman et al.   NEUROMUSCULAR DISORDERS

PERSPECTIVE ARTICLE: Growth factors and cytokines in wound healing

(2008) Stephan Barrientos et al.   WOUND REPAIR AND REGENERATION

Cellular and molecular mechanisms of fibrosis

(2007) TA Wynn   JOURNAL OF PATHOLOGY